"Molybdenum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase.
| Descriptor ID |
D008982
|
| MeSH Number(s) |
D01.268.556.555 D01.268.956.500 D01.552.544.555
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Molybdenum".
Below are MeSH descriptors whose meaning is more specific than "Molybdenum".
This graph shows the total number of publications written about "Molybdenum" by people in this website by year, and whether "Molybdenum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 2002 | 3 | 1 | 4 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Molybdenum" by people in Profiles.
-
Gonzalez-Martin R, Palomar A, Qui?onero A, Pellicer N, Fernandez-Saavedra R, Conde-Vilda E, Quejido AJ, Whitehead C, Scott RT, Dominguez F. The Impact of Essential Trace Elements on Ovarian Response and Reproductive Outcomes following Single Euploid Embryo Transfer. Int J Mol Sci. 2023 Jun 30; 24(13).
-
Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002 Sep 01; 62(17):4854-9.
-
van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia. 2002 Sep-Oct; 4(5):373-9.
-
Liu M, Cohen EJ, Brewer GJ, Laibson PR. Kayser-Fleischer ring as the presenting sign of Wilson disease. Am J Ophthalmol. 2002 Jun; 133(6):832-4.
-
Khan MK, Miller MW, Taylor J, Gill NK, Dick RD, Van Golen K, Brewer GJ, Merajver SD. Radiotherapy and antiangiogenic TM in lung cancer. Neoplasia. 2002 Mar-Apr; 4(2):164-70.
-
Sullivan W, Stensgard B, Caucutt G, Bartha B, McMahon N, Alnemri ES, Litwack G, Toft D. Nucleotides and two functional states of hsp90. J Biol Chem. 1997 Mar 21; 272(12):8007-12.
-
Gingold EL, Wu X, Barnes GT. Contrast and dose with Mo-Mo, Mo-Rh, and Rh-Rh target-filter combinations in mammography. Radiology. 1995 Jun; 195(3):639-44.
-
Bodine PV, Alnemri ES, Litwack G. Synthetic peptides derived from the steroid binding domain block modulator and molybdate action toward the rat glucocorticoid receptor. Receptor. 1995; 5(2):117-22.
-
Wu X, Gingold EL, Barnes GT, Tucker DM. Normalized average glandular dose in molybdenum target-rhodium filter and rhodium target-rhodium filter mammography. Radiology. 1994 Oct; 193(1):83-9.